Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

The Use of Aging Biomarkers to Predict Adverse Outcomes After Cardiac Surgery

Authors not listed

Sapere Bio · 2015

Abstract

Cardiac surgery associated acute kidney injury (CSA-AKI) has been recognized as the second most common cause of hospital acquired AKI. The development of CSA-AKI is independently associated with an increased risk of in-hospital death. There are currently no biomarkers that could identify patients at higher risk for AKI and current risk predictor scores that are based on clinical and demographic information are inadequate. Therefore, a diagnostic test for predicting AKI risk in this clinical context would assist clinicians to optimize surgical strategy and postoperative care to prevent CSA-AKI occurrence and improve patient outcomes. The primary purpose of this study is to measure the association between baseline expression of senescence(definition) markers in blood using SenesceTest and the occurrence of CSA-AKI post surgery.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-14 MST

Cite this

APA
Anonymous. (2015). The Use of Aging Biomarkers to Predict Adverse Outcomes After Cardiac Surgery. <em>Sapere Bio</em>. https://clinicaltrials.gov/study/NCT02496234
Vancouver
Anonymous. The Use of Aging Biomarkers to Predict Adverse Outcomes After Cardiac Surgery. Sapere Bio. 2015.
BibTeX
@misc{anon2015TheUse, title = {The Use of Aging Biomarkers to Predict Adverse Outcomes After Cardiac Surgery}, author = {Anonymous}, journal = {Sapere Bio}, year = {2015}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings